Literature DB >> 9236753

The extent of undiagnosed gestational diabetes mellitus in New South Wales.

R G Moses1, S Colagiuri.   

Abstract

OBJECTIVES: To estimate the number of pregnant women in New South Wales who had not been tested for gestational diabetes mellitus (GDM) during the period 1991-1994.
DESIGN: The number of women not tested for GDM was estimated from the recorded data available in the NSW Midwives Data Collection (MDC) annual reports and compared with three incidence surveys. MAIN OUTCOME MEASURE: The number of pregnant women not tested for GDM.
RESULTS: Over the four-year period, the average annual recorded MDC incidence of GDM was 2.2%. This percentage was adjusted up to 3.3% after review of the MDC validation study and an incidence study. However, the expected incidence of GDM from three incidence surveys was 6.6%. Thus, half of the pregnant women in NSW do not appear to have been tested for GDM.
CONCLUSION: For the four-year period 1991-1994, an-estimated 50% of women in NSW were probably not tested for GDM.

Entities:  

Mesh:

Year:  1997        PMID: 9236753     DOI: 10.5694/j.1326-5377.1997.tb138756.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  3 in total

1.  Usefulness of electronic databases for the detection of unrecognized diabetic patients.

Authors:  Shlomo Vinker; Yaacov Fogelman; Asher Elhayany; Sasson Nakar; Ernesto Kahan
Journal:  Cardiovasc Diabetol       Date:  2003-11-14       Impact factor: 9.951

2.  Surprisingly low compliance to local guidelines for risk factor based screening for gestational diabetes mellitus - A population-based study.

Authors:  Margareta Persson; Anna Winkvist; Ingrid Mogren
Journal:  BMC Pregnancy Childbirth       Date:  2009-11-16       Impact factor: 3.007

Review 3.  Diabetes in pregnancy among indigenous women in Australia, Canada, New Zealand and the United States.

Authors:  Catherine Chamberlain; Bridgette McNamara; Emily D Williams; Daniel Yore; Brian Oldenburg; Jeremy Oats; Sandra Eades
Journal:  Diabetes Metab Res Rev       Date:  2013-05       Impact factor: 4.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.